We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTM
1476
DELISTED
Tata Motors Limited
TTM
$39K ﹤0.01%
3,062
+830
+37% +$9.14K
WFC.PRX
1477
DELISTED
Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu
WFC.PRX
$39K ﹤0.01%
1,500
CIBR icon
1478
First Trust NASDAQ Cybersecurity ETF
CIBR
$14B
$38K ﹤0.01%
1,282
EXEL icon
1479
Exelixis
EXEL
$14.2B
$38K ﹤0.01%
2,222
-800
-26% -$13.6K
HACK icon
1480
Amplify Cybersecurity ETF
HACK
$2.65B
$38K ﹤0.01%
932
IONS icon
1481
Ionis Pharmaceuticals
IONS
$9.14B
$38K ﹤0.01%
646
+440
+214% +$26.2K
UBSI icon
1482
United Bankshares
UBSI
$6.71B
$38K ﹤0.01%
987
WDAY icon
1483
Workday
WDAY
$39.4B
$38K ﹤0.01%
237
+6
+3% +$996
FMX icon
1484
Fomento Económico Mexicano
FMX
$43.5B
$37K ﹤0.01%
402
+147
+58% +$13.5K
FN icon
1485
Fabrinet
FN
$16.1B
$37K ﹤0.01%
583
+52
+10% +$3.01K
INSM icon
1486
Insmed
INSM
$22.6B
$37K ﹤0.01%
1,566
IRBT
1487
DELISTED
iRobot
IRBT
$37K ﹤0.01%
738
+82
+13% +$4.12K
MFG icon
1488
Mizuho Financial
MFG
$123B
$37K ﹤0.01%
12,078
SHO icon
1489
Sunstone Hotel Investors
SHO
$2.19B
$37K ﹤0.01%
2,693
CRC
1490
DELISTED
California Resources Corporation
CRC
$37K ﹤0.01%
4,173
+1,498
+56% +$12.1K
BBD icon
1491
Banco Bradesco
BBD
$38.3B
$36K ﹤0.01%
5,384
+173
+3% +$1.08K
NOK icon
1492
Nokia
NOK
$49.9B
$36K ﹤0.01%
9,715
+723
+8% +$2.84K
PHI icon
1493
PLDT
PHI
$4.32B
$36K ﹤0.01%
1,816
-43
-2% -$900
STT.PRG icon
1494
State Street Corp Series G Preferred Stock
STT.PRG
$425M
$36K ﹤0.01%
1,300
PRFT
1495
DELISTED
Perficient Inc
PRFT
$36K ﹤0.01%
787
+79
+11% +$3.22K
CAMP
1496
DELISTED
CalAmp Corp.
CAMP
$36K ﹤0.01%
164
LTHM
1497
DELISTED
Livent Corporation
LTHM
$36K ﹤0.01%
4,305
+762
+22% +$5.83K
PBCT
1498
DELISTED
People's United Financial Inc
PBCT
$36K ﹤0.01%
2,133
-7,144
-77% -$117K
EGOV
1499
DELISTED
NIC Inc
EGOV
$36K ﹤0.01%
1,660
+299
+22% +$6.54K
CADE
1500
DELISTED
Cadence Bancorporation
CADE
$36K ﹤0.01%
2,060
-7,710
-79% -$129K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.